NLS Pharmaceutics Warrant
NLSPW
NLSPW was delisted on the 30th of October, 2025.
8 hedge funds and large institutions have $485K invested in NLS Pharmaceutics Warrant in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
325% more capital invested
Capital invested by funds: $114K → $485K (+$371K)
4.3% more ownership
Funds ownership: 9.01% → 13.31% (+4.3%)
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$130K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
AIGH Capital Management
Baltimore,
Maryland
| $158K | +$130K | +633,361 | New |
|
|
AC
2
Armistice Capital
New York
| $125K | – | – | – |
|
|
WVP
3
Worth Venture Partners
Fort Lee,
New Jersey
| $49K | – | – | – |
|
|
ACM
4
Altium Capital Management
New York
| $43K | – | – | – |
|
|
AC
5
Ayrton Capital
Westport,
Connecticut
| $43K | – | – | – |
|
|
EAM
6
Empery Asset Management
New York
| $38K | – | – | – |
|
7
Hudson Bay Capital Management
Stamford,
Connecticut
| $25K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $4K | +$2.77K | +13,461 | +645% |
|
|
WAM
9
Warberg Asset Management
Winnetka,
Illinois
| – | -$2K | -12,881 | Closed |
|
NLSPW Hedge Fund Activity: Q3 2022 in Review
8 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in NLS Pharmaceutics Warrant (NLSPW) for Q3 2022, worth a combined $485K — up 325% from $114K a quarter earlier.
Fund positioning in NLSPW was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $130K. The largest seller was Warberg Asset Management, exiting entirely with an estimated $2K sold.
- 8 institutional investors held NLS Pharmaceutics Warrant (NLSPW) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $485K of NLS Pharmaceutics Warrant stock for Q3 2022, up 325% quarter-over-quarter.
- 1 fund opened new NLS Pharmaceutics Warrant positions in Q3 2022 and 1 closed out, a net change of 0 holders.
- The largest NLS Pharmaceutics Warrant buyer in Q3 2022 was AIGH Capital Management, an estimated $130K added.
- The largest NLS Pharmaceutics Warrant seller in Q3 2022 was Warberg Asset Management, an estimated $2K sold.
Based on aggregated 13F filings for Q3 2022.